Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:1002-1009
Published online before print February 7, 2008, doi: 10.1161/HYPERTENSIONAHA.107.107565
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/4/1002    most recent
HYPERTENSIONAHA.107.107565v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chappell, L. C.
Right arrow Articles by Shennan, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chappell, L. C.
Right arrow Articles by Shennan, A. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
*High Blood Pressure
*High Risk Pregnancy
Hazardous Substances DB
*ASCORBIC ACID
*SODIUM ASCORBATE
Related Collections
Right arrow Other hypertension
Right arrow Clinical Studies

(Hypertension. 2008;51:1002.)
© 2008 American Heart Association, Inc.


Go Red Original Articles

Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension

A Prospective Study

Lucy C. Chappell; Stephen Enye; Paul Seed; Annette L. Briley; Lucilla Poston; Andrew H. Shennan

From the Maternal and Fetal Research Unit, Division of Reproduction and Endocrinology, King’s College London School of Biomedical and Health Sciences, London, UK.

Correspondence to Dr Lucy Chappell, Maternal and Fetal Research Unit, Division of Reproduction and Endocrinology, King’s College London School of Biomedical and Health Sciences, London SE1 7EH, UK. E-mail lucy.chappell{at}kcl.ac.uk

Prospective contemporaneous data on the outcome of pregnancies in women with chronic hypertension are sparse. Indices of maternal and perinatal morbidity and mortality were determined in 822 women with chronic hypertension with data prospectively collected and rigorously validated. The incidence of superimposed preeclampsia was 22% (n=180) with early-onset preeclampsia (≤34 weeks gestation) accounting for nearly half of these cases. Delivering an infant <10th customized birthweight centile complicated 48% (87/180) of those with superimposed preeclampsia and 21% (137/642) in those without (relative risk [RR] 2.30; 95% confidence intervals [CI] 1.85 to 2.84). Delivery at <37 weeks gestation occurred in 51% of those with superimposed preeclampsia (98% of these iatrogenic) and 15% without (66% iatrogenic) (RR 3.52; 95% CI 2.79 to 4.45). Using multiple logistic regression, black ethnic origin, raised body mass index, present smoking, booking systolic blood pressure of 130 to 139 mm Hg, and diastolic blood pressure of 80 to 89 mm Hg, a previous history of preeclampsia or eclampsia and chronic renal disease were identified as risk factors for superimposed preeclampsia. Adverse maternal and perinatal outcomes occur in women with chronic hypertension; the prevalence of infants born small for gestational age and preterm is considerably higher than background rates, and is increased further in women with superimposed preeclampsia. Use of customized birthweight centiles provides more accurate determination of fetal growth restriction and highlights the need for greater fetal surveillance in these women. Paradoxically, smoking is an independent risk factor for superimposed preeclampsia in chronic hypertension, in contrast to the protective effect in low-risk pregnant women.


Key Words: hypertension • pregnancy • preeclampsia • maternal morbidity • fetal morbidity • risk factors